Loading…

NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer

NRP1 is a transmembrane glycoprotein that is highly expressed in a variety of tumors. There is evidence that NRP1 can enhance the stem cell properties of tumor cells, which are thought to be resistant to radiotherapy. This study aims to elucidate the potential mechanism of NRP1 in radiation resistan...

Full description

Saved in:
Bibliographic Details
Published in:Apoptosis (London) 2023-02, Vol.28 (1-2), p.233-246
Main Authors: Wang, Yang, Zhang, Lin, Sun, Xiao-Lin, Lu, Ya-Chun, Chen, Si, Pei, Dong-Sheng, Zhang, Lan-Sheng
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c508t-8e206a86f96f46de43b7f12932119417a62c8ca70cb717b321653facb93031463
cites cdi_FETCH-LOGICAL-c508t-8e206a86f96f46de43b7f12932119417a62c8ca70cb717b321653facb93031463
container_end_page 246
container_issue 1-2
container_start_page 233
container_title Apoptosis (London)
container_volume 28
creator Wang, Yang
Zhang, Lin
Sun, Xiao-Lin
Lu, Ya-Chun
Chen, Si
Pei, Dong-Sheng
Zhang, Lan-Sheng
description NRP1 is a transmembrane glycoprotein that is highly expressed in a variety of tumors. There is evidence that NRP1 can enhance the stem cell properties of tumor cells, which are thought to be resistant to radiotherapy. This study aims to elucidate the potential mechanism of NRP1 in radiation resistance. We transfected NRP1 siRNA and plasmid in breast cancer cells to detect the expression of cancer stem cell markers by western blot and qRT-PCR. The effect of NRP1 on radiotherapy resistance was assesses by immunofluorescence and flow cytometry. In vivo, we established xenograft tumor model treating with shRNA-NRP1 to assess radiotherapy sensitivity. We found that NRP1 could enhance the stem cell properties and confer radioresistance of breast cancer cells. Mechanistically, we proved that NRP1 reduced IR-induced apoptosis by downregulation of Bcl-2 via methyltransferase WTAP in m6A-depentent way. It is suggested that these molecules may be the therapeutic targets for improving the efficacy of radiotherapy for breast cancer.
doi_str_mv 10.1007/s10495-022-01784-3
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2732541823</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A738441693</galeid><sourcerecordid>A738441693</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-8e206a86f96f46de43b7f12932119417a62c8ca70cb717b321653facb93031463</originalsourceid><addsrcrecordid>eNp9kU1rFjEUhQdRbK3-ARcScOMmNV-TZJZj8QtKLaWiu5DJ3KkpM8lrkhG68L-b8a0WRSSEhHufc7jJaZqnlBxTQtTLTInoWkwYw4QqLTC_1xzSVnEsVfv5fr1zSbCmuj1oHuV8TQjhmouHzQGXnNdNDpvvZxfnFLkYSvLDWiCjElEusATIGdkwol0sEIq3Wy_Z0ccE2edigwP0zVv06bI_xwuMGzGiRfZogfLlZrbFx4DihF65GTO0XJz1yAc0JLC5ILfp0-PmwWTnDE9uz6Pm45vXlyfv8OmHt-9P-lPsWqIL1sCItFpOnZyEHEHwQU2UdZxR2gmqrGROO6uIGxRVQy3Llk_WDR0nnArJj5oXe99dil9XyMUsPjuYZxsgrtkwxVkrqGa8os__Qq_jmkKdrlKqY60mVNxRV3YG48MUS7JuMzW94loIKrvN6_gfVF0jLL7-OUy-1v8QsL3ApZhzgsnskl9sujGUmC1zs8_c1MzNz8zNJnp2O_E61Bx-S36FXAG-B3JthStId0_6j-0PTIGz5A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2779258014</pqid></control><display><type>article</type><title>NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer</title><source>Springer Link</source><creator>Wang, Yang ; Zhang, Lin ; Sun, Xiao-Lin ; Lu, Ya-Chun ; Chen, Si ; Pei, Dong-Sheng ; Zhang, Lan-Sheng</creator><creatorcontrib>Wang, Yang ; Zhang, Lin ; Sun, Xiao-Lin ; Lu, Ya-Chun ; Chen, Si ; Pei, Dong-Sheng ; Zhang, Lan-Sheng</creatorcontrib><description>NRP1 is a transmembrane glycoprotein that is highly expressed in a variety of tumors. There is evidence that NRP1 can enhance the stem cell properties of tumor cells, which are thought to be resistant to radiotherapy. This study aims to elucidate the potential mechanism of NRP1 in radiation resistance. We transfected NRP1 siRNA and plasmid in breast cancer cells to detect the expression of cancer stem cell markers by western blot and qRT-PCR. The effect of NRP1 on radiotherapy resistance was assesses by immunofluorescence and flow cytometry. In vivo, we established xenograft tumor model treating with shRNA-NRP1 to assess radiotherapy sensitivity. We found that NRP1 could enhance the stem cell properties and confer radioresistance of breast cancer cells. Mechanistically, we proved that NRP1 reduced IR-induced apoptosis by downregulation of Bcl-2 via methyltransferase WTAP in m6A-depentent way. It is suggested that these molecules may be the therapeutic targets for improving the efficacy of radiotherapy for breast cancer.</description><identifier>ISSN: 1360-8185</identifier><identifier>EISSN: 1573-675X</identifier><identifier>DOI: 10.1007/s10495-022-01784-3</identifier><identifier>PMID: 36333630</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Apoptosis ; Apoptosis - radiation effects ; Bcl-2 protein ; Biochemistry ; Biomedical and Life Sciences ; Biomedicine ; Breast cancer ; Breast Neoplasms - pathology ; Cancer Research ; Cell Biology ; Cell Cycle Proteins - metabolism ; Cell Line, Tumor ; Disease Models, Animal ; Ethylenediaminetetraacetic acid ; Female ; Flow cytometry ; Glycoproteins ; Humans ; Immunofluorescence ; Messenger RNA ; Methylation ; Methyltransferase ; Methyltransferases ; mRNA ; N6-methyladenosine ; Oncology ; Radiation therapy ; Radiation tolerance ; Radioresistance ; Radiotherapy ; RNA Splicing Factors - metabolism ; RNA, Messenger - metabolism ; RNA, Small Interfering - genetics ; siRNA ; Stem cells ; Therapeutic targets ; Tumor cells ; Tumors ; Virology ; Xenografts ; Xenotransplantation</subject><ispartof>Apoptosis (London), 2023-02, Vol.28 (1-2), p.233-246</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>COPYRIGHT 2023 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-8e206a86f96f46de43b7f12932119417a62c8ca70cb717b321653facb93031463</citedby><cites>FETCH-LOGICAL-c508t-8e206a86f96f46de43b7f12932119417a62c8ca70cb717b321653facb93031463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36333630$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Yang</creatorcontrib><creatorcontrib>Zhang, Lin</creatorcontrib><creatorcontrib>Sun, Xiao-Lin</creatorcontrib><creatorcontrib>Lu, Ya-Chun</creatorcontrib><creatorcontrib>Chen, Si</creatorcontrib><creatorcontrib>Pei, Dong-Sheng</creatorcontrib><creatorcontrib>Zhang, Lan-Sheng</creatorcontrib><title>NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer</title><title>Apoptosis (London)</title><addtitle>Apoptosis</addtitle><addtitle>Apoptosis</addtitle><description>NRP1 is a transmembrane glycoprotein that is highly expressed in a variety of tumors. There is evidence that NRP1 can enhance the stem cell properties of tumor cells, which are thought to be resistant to radiotherapy. This study aims to elucidate the potential mechanism of NRP1 in radiation resistance. We transfected NRP1 siRNA and plasmid in breast cancer cells to detect the expression of cancer stem cell markers by western blot and qRT-PCR. The effect of NRP1 on radiotherapy resistance was assesses by immunofluorescence and flow cytometry. In vivo, we established xenograft tumor model treating with shRNA-NRP1 to assess radiotherapy sensitivity. We found that NRP1 could enhance the stem cell properties and confer radioresistance of breast cancer cells. Mechanistically, we proved that NRP1 reduced IR-induced apoptosis by downregulation of Bcl-2 via methyltransferase WTAP in m6A-depentent way. It is suggested that these molecules may be the therapeutic targets for improving the efficacy of radiotherapy for breast cancer.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - radiation effects</subject><subject>Bcl-2 protein</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - pathology</subject><subject>Cancer Research</subject><subject>Cell Biology</subject><subject>Cell Cycle Proteins - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Disease Models, Animal</subject><subject>Ethylenediaminetetraacetic acid</subject><subject>Female</subject><subject>Flow cytometry</subject><subject>Glycoproteins</subject><subject>Humans</subject><subject>Immunofluorescence</subject><subject>Messenger RNA</subject><subject>Methylation</subject><subject>Methyltransferase</subject><subject>Methyltransferases</subject><subject>mRNA</subject><subject>N6-methyladenosine</subject><subject>Oncology</subject><subject>Radiation therapy</subject><subject>Radiation tolerance</subject><subject>Radioresistance</subject><subject>Radiotherapy</subject><subject>RNA Splicing Factors - metabolism</subject><subject>RNA, Messenger - metabolism</subject><subject>RNA, Small Interfering - genetics</subject><subject>siRNA</subject><subject>Stem cells</subject><subject>Therapeutic targets</subject><subject>Tumor cells</subject><subject>Tumors</subject><subject>Virology</subject><subject>Xenografts</subject><subject>Xenotransplantation</subject><issn>1360-8185</issn><issn>1573-675X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kU1rFjEUhQdRbK3-ARcScOMmNV-TZJZj8QtKLaWiu5DJ3KkpM8lrkhG68L-b8a0WRSSEhHufc7jJaZqnlBxTQtTLTInoWkwYw4QqLTC_1xzSVnEsVfv5fr1zSbCmuj1oHuV8TQjhmouHzQGXnNdNDpvvZxfnFLkYSvLDWiCjElEusATIGdkwol0sEIq3Wy_Z0ccE2edigwP0zVv06bI_xwuMGzGiRfZogfLlZrbFx4DihF65GTO0XJz1yAc0JLC5ILfp0-PmwWTnDE9uz6Pm45vXlyfv8OmHt-9P-lPsWqIL1sCItFpOnZyEHEHwQU2UdZxR2gmqrGROO6uIGxRVQy3Llk_WDR0nnArJj5oXe99dil9XyMUsPjuYZxsgrtkwxVkrqGa8os__Qq_jmkKdrlKqY60mVNxRV3YG48MUS7JuMzW94loIKrvN6_gfVF0jLL7-OUy-1v8QsL3ApZhzgsnskl9sujGUmC1zs8_c1MzNz8zNJnp2O_E61Bx-S36FXAG-B3JthStId0_6j-0PTIGz5A</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Wang, Yang</creator><creator>Zhang, Lin</creator><creator>Sun, Xiao-Lin</creator><creator>Lu, Ya-Chun</creator><creator>Chen, Si</creator><creator>Pei, Dong-Sheng</creator><creator>Zhang, Lan-Sheng</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RQ</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>20230201</creationdate><title>NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer</title><author>Wang, Yang ; Zhang, Lin ; Sun, Xiao-Lin ; Lu, Ya-Chun ; Chen, Si ; Pei, Dong-Sheng ; Zhang, Lan-Sheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-8e206a86f96f46de43b7f12932119417a62c8ca70cb717b321653facb93031463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - radiation effects</topic><topic>Bcl-2 protein</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - pathology</topic><topic>Cancer Research</topic><topic>Cell Biology</topic><topic>Cell Cycle Proteins - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Disease Models, Animal</topic><topic>Ethylenediaminetetraacetic acid</topic><topic>Female</topic><topic>Flow cytometry</topic><topic>Glycoproteins</topic><topic>Humans</topic><topic>Immunofluorescence</topic><topic>Messenger RNA</topic><topic>Methylation</topic><topic>Methyltransferase</topic><topic>Methyltransferases</topic><topic>mRNA</topic><topic>N6-methyladenosine</topic><topic>Oncology</topic><topic>Radiation therapy</topic><topic>Radiation tolerance</topic><topic>Radioresistance</topic><topic>Radiotherapy</topic><topic>RNA Splicing Factors - metabolism</topic><topic>RNA, Messenger - metabolism</topic><topic>RNA, Small Interfering - genetics</topic><topic>siRNA</topic><topic>Stem cells</topic><topic>Therapeutic targets</topic><topic>Tumor cells</topic><topic>Tumors</topic><topic>Virology</topic><topic>Xenografts</topic><topic>Xenotransplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Yang</creatorcontrib><creatorcontrib>Zhang, Lin</creatorcontrib><creatorcontrib>Sun, Xiao-Lin</creatorcontrib><creatorcontrib>Lu, Ya-Chun</creatorcontrib><creatorcontrib>Chen, Si</creatorcontrib><creatorcontrib>Pei, Dong-Sheng</creatorcontrib><creatorcontrib>Zhang, Lan-Sheng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Career and Technical Education</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Apoptosis (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Yang</au><au>Zhang, Lin</au><au>Sun, Xiao-Lin</au><au>Lu, Ya-Chun</au><au>Chen, Si</au><au>Pei, Dong-Sheng</au><au>Zhang, Lan-Sheng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer</atitle><jtitle>Apoptosis (London)</jtitle><stitle>Apoptosis</stitle><addtitle>Apoptosis</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>28</volume><issue>1-2</issue><spage>233</spage><epage>246</epage><pages>233-246</pages><issn>1360-8185</issn><eissn>1573-675X</eissn><abstract>NRP1 is a transmembrane glycoprotein that is highly expressed in a variety of tumors. There is evidence that NRP1 can enhance the stem cell properties of tumor cells, which are thought to be resistant to radiotherapy. This study aims to elucidate the potential mechanism of NRP1 in radiation resistance. We transfected NRP1 siRNA and plasmid in breast cancer cells to detect the expression of cancer stem cell markers by western blot and qRT-PCR. The effect of NRP1 on radiotherapy resistance was assesses by immunofluorescence and flow cytometry. In vivo, we established xenograft tumor model treating with shRNA-NRP1 to assess radiotherapy sensitivity. We found that NRP1 could enhance the stem cell properties and confer radioresistance of breast cancer cells. Mechanistically, we proved that NRP1 reduced IR-induced apoptosis by downregulation of Bcl-2 via methyltransferase WTAP in m6A-depentent way. It is suggested that these molecules may be the therapeutic targets for improving the efficacy of radiotherapy for breast cancer.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>36333630</pmid><doi>10.1007/s10495-022-01784-3</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1360-8185
ispartof Apoptosis (London), 2023-02, Vol.28 (1-2), p.233-246
issn 1360-8185
1573-675X
language eng
recordid cdi_proquest_miscellaneous_2732541823
source Springer Link
subjects Animals
Apoptosis
Apoptosis - radiation effects
Bcl-2 protein
Biochemistry
Biomedical and Life Sciences
Biomedicine
Breast cancer
Breast Neoplasms - pathology
Cancer Research
Cell Biology
Cell Cycle Proteins - metabolism
Cell Line, Tumor
Disease Models, Animal
Ethylenediaminetetraacetic acid
Female
Flow cytometry
Glycoproteins
Humans
Immunofluorescence
Messenger RNA
Methylation
Methyltransferase
Methyltransferases
mRNA
N6-methyladenosine
Oncology
Radiation therapy
Radiation tolerance
Radioresistance
Radiotherapy
RNA Splicing Factors - metabolism
RNA, Messenger - metabolism
RNA, Small Interfering - genetics
siRNA
Stem cells
Therapeutic targets
Tumor cells
Tumors
Virology
Xenografts
Xenotransplantation
title NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T14%3A09%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NRP1%20contributes%20to%20stemness%20and%20potentiates%20radioresistance%20via%20WTAP-mediated%20m6A%20methylation%20of%20Bcl-2%20mRNA%20in%20breast%20cancer&rft.jtitle=Apoptosis%20(London)&rft.au=Wang,%20Yang&rft.date=2023-02-01&rft.volume=28&rft.issue=1-2&rft.spage=233&rft.epage=246&rft.pages=233-246&rft.issn=1360-8185&rft.eissn=1573-675X&rft_id=info:doi/10.1007/s10495-022-01784-3&rft_dat=%3Cgale_proqu%3EA738441693%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c508t-8e206a86f96f46de43b7f12932119417a62c8ca70cb717b321653facb93031463%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2779258014&rft_id=info:pmid/36333630&rft_galeid=A738441693&rfr_iscdi=true